Pterostilbene and Resveratrol Photoaging Protection: 2026 Scoping Review

A scoping review in Skin Health and Disease compiled the photoaging protection mechanisms of resveratrol and pterostilbene. Combined clinical evidence and pharmacological differences show pterostilbene with pharmacological advantages and resveratrol with greater accumulated human clinical evidence — a differentiated positioning.

Differences between the two molecules

Resveratrol and pterostilbene belong to the same stilbene polyphenol family. Plants (grapes, blueberries, peanuts) produce them as defense molecules in response to stress (UV, fungi, damage).

The molecular structure differences are small but pharmacological consequences are large.

Resveratrol (trans-resveratrol): Two hydroxyl (-OH) groups.

Pterostilbene: Two methoxy (-OCH3) groups. The methylated form of resveratrol.

This difference dramatically changes pharmacokinetics.

Lipophilicity: Pterostilbene roughly 4x resveratrol. Better cell membrane crossing.

Oral bioavailability: Pterostilbene ~80%, resveratrol ~20%. Same dose intake produces dramatically different blood levels.

Half-life: Pterostilbene ~105 min, resveratrol ~14 min. 7x+ difference.

Blood-brain barrier: Pterostilbene superior.

These pharmacological advantages are why pterostilbene is called “next-generation resveratrol.”

Photoaging protection mechanisms

The scoping review compiled the protection paths of both molecules.

SIRT1 activation: Sirtuin 1 is an NAD+-dependent protein deacetylase that regulates cellular aging and DNA repair. Both molecules activate SIRT1 for photoaging protection.

Nrf2 pathway activation: A key transcription factor activating antioxidant defense systems (glutathione peroxidase, heme oxygenase). Clears reactive oxygen species (ROS) from UV damage.

MMP inhibition: Matrix metalloproteinases degrade collagen and elastin. UV activates MMPs. Both molecules inhibit MMP activity to protect ECM.

Inflammatory pathway inhibition: Partial inhibition of NF-κB, COX-2. Reduces chronic photoaging inflammation baseline.

Telomere protection: Some data signal slowed telomere shortening.

Mitochondrial function protection: UV is a major mitochondrial damage source. Both molecules stabilize mitochondrial membranes and protect ATP production.

These multi-mechanism actions enable multi-layered protection from photoaging.

Position of clinical data

Resveratrol: Relatively rich human RCT evidence. This quarter’s 132-participant 8-week RCT showed topical + oral combination meaningfully reduced fine wrinkles. Multiple topical trials report skin elasticity, fine line, and wrinkle depth improvements.

Pterostilbene: Pharmacological advantages are consistent in animal models and in vitro data. Human clinical data is still limited. A 31-participant 28-day trial of 0.1% pterostilbene topical emulsion reported skin elasticity, firmness, and wrinkle reduction. Larger follow-up trials needed.

The data stages differ for the same molecular family. Pharmacological superiority doesn’t automatically translate to clinical superiority.

Which to choose

Guidance from the scoping review.

Resveratrol: When prioritizing clinical evidence. Topical 0.5-1% or oral 100-500 mg/day are typical clinical doses. Low oral bioavailability is partially compensated through micronization, liposomal formulations.

Pterostilbene: When expecting stronger pharmacological effects. Oral 50-250 mg/day, topical 0.05-0.5%. But limited human clinical data makes effect-size prediction harder.

Both: Synergy possible. Same SIRT1, Nrf2, antioxidant pathways activated through different pharmacokinetics. Some commercial supplements combine the two.

Topical vs oral

Topical: Direct skin reach. Most direct for photoaging targets. But large-molecule reach to dermis can be limited.

Oral: Systemic distribution. Skin-external effects (cognitive, cardiovascular) also possible. But low oral bioavailability (resveratrol) reduces effect.

Combination: This quarter’s 132-participant RCT showed topical + oral resveratrol combination outperformed monotherapy. Two paths complement.

Dietary sources

Stilbene polyphenol food sources.

Resveratrol: Red grape skins, red wine, blueberries, peanuts. ~0.5-1 mg per glass of red wine. Reaching clinical doses (100-500 mg) is hard.

Pterostilbene: Blueberries, grapes, some medicinal plants. ~0.1-0.2 mg per cup of blueberries. Reaching clinical doses through diet is very difficult.

Synergistic foods: Purple sweet potato, red cabbage, berries, dark chocolate (polyphenol diversity).

Diet builds the foundation with other polyphenols; targeted effects are supplemented.

Connection to other aging mechanisms

Stilbene polyphenols are one axis of the aging mechanism matrix.

Mitochondria: SIRT1 activation supports mitochondrial function. Different path from Lancôme x Timeline’s Urolithin A mitophagy target.

NAD+ system: SIRT1 is NAD+-dependent. Possible synergy with this quarter’s NMN and NR (NAD+ boosters).

Antioxidants: Nrf2 pathway. Complements vitamin C, E, carotenoids.

Autophagy: Some data show SIRT1 → autophagy signaling. Different path from spermidine but same target.

Photoaging: UV protection (SPF) + retinoids + vitamin C + stilbene polyphenols. Multi-layered protection matrix.

Who fits

Photoaging-concerned populations.

40+ with daily UV exposure: One option in the photoaging protection matrix.

Photoaging signs (fine lines, pigmentation, sagging): Try topical + oral combination.

Autoimmune or chronic inflammatory skin conditions: Anti-inflammatory adjunct.

Aging mechanism-targeting interest: Part of mitochondrial, NAD+, SIRT1 matrix.

Who should be careful

Pregnancy/breastfeeding: Insufficient data. Use cautiously.

Drug interactions: Resveratrol can interact with warfarin and antiplatelet drugs. Consult a clinician.

Hormone-responsive tumors: Resveratrol has weak estrogenic activity. Consult a clinician for breast cancer or other hormone-responsive tumor history.

High dose (resveratrol 1 g/day+): Increased GI side effects. Use within clinical doses.

Daily guide

General priorities for the photoaging protection matrix.

Layer 1: UV protection. SPF 30+, hats, clothing. The most powerful primary prevention.

Layer 2: Retinoids (evening) + vitamin C (morning). Validated topical matrix.

Layer 3: Antioxidant foundation. Diet (berries, colorful vegetables), vitamin C, E.

Layer 4: Polyphenol supplementation (optional). Resveratrol 100-500 mg/day or pterostilbene 50-250 mg/day. Lower priority if diet is adequate.

Layer 5: Procedure/medical options. For advanced photoaging, IPL, prescription retinoids, photodynamic therapy.

Stilbene polyphenols are one targeted option for photoaging, not a cure-all. Use within the matrix matched to your stage and target.